{"filing":{"accession_number":"0001723464-26-000048","cik":"0001723464","ticker":"BHST","company_name":"BIOHARVEST SCIENCES INC.","form":"6-K","filing_date":"2026-09-03","report_date":"2026-09-03","primary_document":"bhsc_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723464/000172346426000048/bhsc_6k.htm"},"events":[{"id":31564,"run_id":28972,"accession_number":"0001723464-26-000048","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"BioHarvest announces its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with trading expected to commence September 8, 2026. This is a material operational and strategic milestone—expanding market access and investor reach—but does not fit the specific event categories (it is not M\u0026A, a debt/equity issuance, a delisting risk, or a governance appointment/departure). The dual listing is a significant business development that would affect a reasonable investor's assessment of the company's strategic positioning and liquidity.","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-09-03","form":"6-K","submitted_at":null,"items":[{"id":34491,"accession_number":"0001723464-26-000048","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioHarvest announces its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with trading expected to commence September 8, 2026. This is a material operational and strategic milestone—expanding market access and investor reach—but does not fit the specific event categories (it is not M\u0026A, a debt/equity issuance, a delisting risk, or a governance appointment/departure). The dual listing is a significant business development that would affect a reasonable investor's assessment of the company's strategic positioning and liquidity.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-03T19:23:01.188669+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34491,"accession_number":"0001723464-26-000048","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioHarvest announces its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with trading expected to commence September 8, 2026. This is a material operational and strategic milestone—expanding market access and investor reach—but does not fit the specific event categories (it is not M\u0026A, a debt/equity issuance, a delisting risk, or a governance appointment/departure). The dual listing is a significant business development that would affect a reasonable investor's assessment of the company's strategic positioning and liquidity.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-03T19:23:01.188669+00:00","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-09-03"}]}